We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
(-5.7%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-7.96%
Top 10 Holdings %
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$7.87M |
| 2 |
UiPath
PATH
|
+$6.99M |
| 3 |
Marqeta
MQ
|
+$6.41M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.72M |
| 5 |
FIGS
FIGS
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MongoDB
MDB
|
+$7M |
| 2 |
Charles River Laboratories
CRL
|
+$6.37M |
| 3 |
Floor & Decor
FND
|
+$5.83M |
| 4 |
Bruker
BRKR
|
+$5.34M |
| 5 |
Asana
ASAN
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Healthcare | 21.49% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPH
376
DELISTED
Tri Pointe Homes
TPH
| $941K | 0.07% |
33,738
+403
| +1% | +$10.1K |
|
|
ALLK
377
DELISTED
Allakos
ALLK
| $940K | 0.07% |
+96,046
| New | +$7.87M |
|
|
KYNB
378
Kyntra Bio
KYNB
$28.2M
| $934K | 0.07% |
+2,650
| New | +$825K |
|
379
Immunovant
IMVT
$7.8B
| $930K | 0.07% |
+109,138
| New | +$901K |
|
380
Apollo Global Management
APO
$69.7B
| $921K | 0.07% |
+12,711
| New | +$917K |
|
|
DVAX
381
DELISTED
Dynavax Technologies
DVAX
| $919K | 0.07% |
+65,298
| New | +$1.07M |
|
382
Upwork
UPWK
$1.17B
| $917K | 0.07% |
26,854
-67,546
| -72% | -$2.99M |
|
383
Metropolitan Bank Holding Corp
MCB
$1.15B
| $915K | 0.07% |
8,589
+3,889
| +83% | +$370K |
|
384
CEVA Inc
CEVA
$848M
| $912K | 0.07% |
21,100
-5,300
| -20% | -$237K |
|
385
Fortinet
FTNT
$107B
| $911K | 0.07% |
+12,670
| New | +$834K |
|
|
TSVT
386
DELISTED
2seventy bio
TSVT
| $911K | 0.07% |
+35,543
| New | +$1.11M |
|
387
Marten Transport
MRTN
$1.22B
| $910K | 0.07% |
53,002
-1,340
| -2% | -$22.2K |
|
388
Westlake Corp
WLK
$9.14B
| $909K | 0.07% |
+9,357
| New | +$912K |
|
389
Lincoln National
LNC
$8.05B
| $907K | 0.07% |
+13,292
| New | +$938K |
|
390
MaxLinear
MXL
$5.18B
| $906K | 0.07% |
+12,019
| New | +$770K |
|
391
Intuit
INTU
$90.2B
| $901K | 0.07% |
+1,400
| New | +$864K |
|
392
Tronox
TROX
$944M
| $899K | 0.07% |
+37,403
| New | +$895K |
|
393
F5
FFIV
$22.7B
| $889K | 0.07% |
+3,633
| New | +$807K |
|
394
Royal Gold
RGLD
$16.4B
| $887K | 0.07% |
+8,431
| New | +$850K |
|
|
RNAM
395
DELISTED
Avidity Biosciences
RNAM
| $885K | 0.07% |
37,214
+2,814
| +8% | +$67.2K |
|
396
Universal Health Services
UHS
$10.1B
| $884K | 0.07% |
+6,814
| New | +$876K |
|
397
Essent Group
ESNT
$6.28B
| $882K | 0.07% |
19,365
+13,465
| +228% | +$617K |
|
398
NVIDIA
NVDA
$4.67T
| $882K | 0.07% |
+30,000
| New | +$825K |
|
399
Sana Biotechnology
SANA
$860M
| $882K | 0.07% |
57,005
-16,613
| -23% | -$320K |
|
400
Lands' End
LE
$376M
| $878K | 0.07% |
44,732
-1,007
| -2% | -$23.4K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q4 2021 Portfolio in Review
As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, PDT Partners opened a new position in Allakos worth $940K.
- PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
- PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
- PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
- PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
- PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
- PDT Partners opened 330 new positions and closed 229 in Q4 2021.
- PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.
Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.